Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Miniaturized Clinical Test Rapidly Detects Antibiotic Resistance

By LabMedica International staff writers
Posted on 07 Sep 2016
A new microfluidic concept for multi-analyte testing in a dipstick format, termed “Lab-on-a-Stick”, that combines the simplicity of dipstick tests with the high performance of microfluidic devices has been developed.

Lab-on-a-stick tests are ideally suited to analysis of particulate samples such as mammalian or bacterial cells and capable of performing multiple different parallel microfluidic assays when dipped into a single sample with results recorded optically and a portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed.

Scientists at Loughborough University (UK) and their colleagues carried out different cellular tests to demonstrate the full potential of Lab-on-a-Stick devices for a range of clinical situations. More...
The utility of this new diagnostics format was demonstrated by performing three types of multiplex cellular assays that are challenging to perform in conventional dipsticks: instantaneous ABO blood typing; microbial identification; and antibiotic minimum inhibitory (MIC) concentration measurement.

Anti-microbial resistance was measured with Escherichia coli samples typical of common urinary tract infection (UTIs). UTIs can be hard to treat with antibiotics because antibiotic resistance is so common and laboratory testing takes at least two days. The team demonstrated the advantage of using the microcapillary film which enables 10 different concentrations of antibiotic per sample to be tested with a single test strip.

To identify bacteria, many different tests must be performed on every sample, illustrating again the benefits of microcapillary film which performs 10 tests per test strip. This study demonstrated a four-hour test to distinguish two very closely related bacteria, a harmless laboratory strain of E. coli from Salmonella enterica that causes food poisoning. For ABO blood typing, a simple blood test that takes only two minutes was miniaturized and the results were recorded using an everyday digital camera.

Alexander D. Edwards, PhD, an associate professor and co-author of the study, said, “This is the latest demonstration of our exciting new technology called microcapillary film. What we have done is to develop a low cost way of making thousands of miniature test tubes, so that we can use them for many important applications. Lab-on-a-Stick shows yet again how versatile these microscopic test tubes are.” The study was first published online on June 23, 2016, in the journal Lab on a Chip.

Related Links:
Loughborough University


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.